Gumiton, Princess D.
HRN: 28-29-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2025
CEFUROXIME 750MG (VIAL)
12/16/2025
12/23/2025
IV
670mg
Q8
UTI, URTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary TractURTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes